BSA Icon

4. BIOTECH SUMMIT AUSTRIA 2026

13 – 14 Oct 2026 | Innsbruck, Austria

WuXi AppTec

Company

www.wuxiapptec.com/Shanghai, China
27 profile visits

About

Social media

Areas of activity

BIOLOGY / BIOTECHNOLOGY

AI in Drug DiscoveryBiochemistry / BiophysicsBiologicsCellular and Molecular BiologyEnzymology/Protein Engineering/FermentationIn vitro Testing, TrialsMolecular designNew ModalitiesProtein EngineeringSynthetic BiologyTherapeutic DevelopmentToxicologySmall Molecules

THERAPEUTIC AREA

Cardiology/Vascular DiseasesGenetic DiseaseInfections and Infectious DiseasesOncologyOphthalmologyPharmacology/ToxicologyPulmonary/Respiratory DiseasesRare DiseaseVaccines

VALUE CHAIN

Preclinical Development

Representatives

Director, Business Development

WuXi AppTec

Senior Business Development Manager, EU

WuXi AppTec

Business Development Director, Europe

WuXi AppTec

Marketplace (1)

  • Service

    Integrated CMC development for DS and DP with accelerated timelines

    We deliver CMC development for small molecules within 7-8 months (DS/DP) and for PROTACs and molecular glues (and TIDES) within ~10 months. Integrated DMPK, toxicology, and bioanalytical services are available within the same timeline.

    Author

    Business Development Director, Europe at WuXi AppTec

    Gräfelfing, Germany